Curanex Pharmaceuticals Inc Common Stock Cash Flow Reinvestment Rate
Curanex Pharmaceuticals Inc Common Stock cash flow reinvestment rate. Curanex Pharmaceuticals Inc Common Stock (CURX) has a Cash Flow Reinvestment Rate of 0.00x as of December 2022, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $3.34K. Explore Curanex Pharmaceuticals Inc Common Stock cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Curanex Pharmaceuticals Inc Common Stock (2022–2022)
Cash flow reinvestment rate of Curanex Pharmaceuticals Inc Common Stock from 2022 to 2022. Historical reinvestment intensity for Curanex Pharmaceuticals Inc Common Stock across 1 annual periods. Also explore CURX year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Curanex Pharmaceuticals Inc Common Stock Cash Flow Reinvestment Rate by Year (2022–2022)
Curanex Pharmaceuticals Inc Common Stock cash flow reinvestment rate by year from 2022 to 2022. Year-by-year capital reinvestment analysis for Curanex Pharmaceuticals Inc Common Stock. For the full cash flow conversion analysis, see CURX cash generation efficiency.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.00x | $0.00 | $3.34K | $0.00 | — |